… Combination therapies that combine two or more therapeutic agents or modalities, such as
photodynamic or photothermal therapies, … several approaches for delivering erlotinib by using …

… this synergistic therapy into in vivo anticancer therapy and … C 18 -L) that contained erlotinib/DOX
combination and produced a … Using the knowledge of synergistic combination therapies …

… -Cs) as stable carriers to deliver erlotinib to the target. We loaded erlotinib into Apt-Cs-anchored …
their nontargeted liposomal counterparts in delivering erlotinib to EGFR-mutated cancer …

… (LPH NPs) to co-deliver erlotinib (ERL) and bevacizumab (… a promising system for the
combination therapy of NSCLC. … that ERL and BEV combination therapy in NSCLC produced a …

… combination therapies should lower the doses of drugs with non-overlapping toxicity and
achieve enhanced therapeutic … In the present study, we designed a combined drug delivery …

… To illustrate, drugs in combination therapy target solid cancers … Also, combination therapy
offers the prospect of reducing … One study was found that small-dose combination therapy of …

… Drug delivery systems (DDSs) have provided great potentials in diagnosis and therapy of
various … In this regard, use of nanocarriers for delivery of anticancer therapeutic agents is …

… Currently, the commonly used combined therapies for NSCLC mainly include combining …
-TKIs for ICG delivery could be a promising therapeutic agent for NSCLC therapy. This TDDS …

… : Erlotinib (ELTN)-based targeted therapy … delivery system based on Food and Drug
Administration (FDA)-approved poly(ethylene glycol) (PEG)-poly(lactic acid) (PLA) for the co-delivery …

… therapeutic effects for combination therapy, multiple drugs need to be co-encapsulated for
co-delivery … For instance, liposomes were used to achieve the sequential co-delivery of Ei and …